(NASDAQ: SGHT) Sight Sciences's forecast annual revenue growth rate of 9.73% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.57%.
Sight Sciences's revenue in 2025 is $78,109,000.On average, 3 Wall Street analysts forecast SGHT's revenue for 2025 to be $3,825,644,299, with the lowest SGHT revenue forecast at $3,818,406,007, and the highest SGHT revenue forecast at $3,832,675,783. On average, 3 Wall Street analysts forecast SGHT's revenue for 2026 to be $4,484,484,007, with the lowest SGHT revenue forecast at $4,255,598,863, and the highest SGHT revenue forecast at $4,849,707,556.
In 2027, SGHT is forecast to generate $5,374,121,835 in revenue, with the lowest revenue forecast at $4,723,502,760 and the highest revenue forecast at $6,492,437,999.